Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Cardinal Health | 5.41% | $2.06M | $51.83B | 77.68% | 66 Neutral | |
| Eli Lilly & Co | 5.19% | $1.97M | $969.02B | 19.67% | 72 Outperform | |
| Waste Management | 4.98% | $1.89M | $93.46B | 1.36% | 76 Outperform | |
| Johnson & Johnson | 4.93% | $1.88M | $574.26B | 53.70% | 78 Outperform | |
| McKesson | 4.88% | $1.85M | $114.55B | 61.73% | 62 Neutral | |
| Rentokil Initial | 4.86% | $1.85M | $16.16B | 24.57% | 66 Neutral | |
| Chubb | 4.45% | $1.69M | $128.40B | 23.05% | 80 Outperform | |
| Coca-Cola | 4.40% | $1.67M | $330.41B | 13.48% | 75 Outperform | |
| Casey's General | 4.27% | $1.62M | $24.23B | 51.36% | 68 Neutral | |
| Northrop Grumman | 4.22% | $1.60M | $97.22B | 48.24% | 76 Outperform |